3 ms·
The cost isn't justified by the cost of producing the dose, it's justified by the cost of testing a drug like that divided by the small number of recipients.
by PaulHoule 2y ago
The cost isn't justified by the cost of producing the dose, it's justified by the cost of testing a drug like that divided by the small number of recipients. Other gene therapies for rare diseases are priced accordingly, insurance companies will pay because they a worth a lot.
- JPLeRouzic 2y agoPaul, If you read the article carefully, you will note that AveXis has spent roughly $13M on preclinical and clinical trials, while the drug costs more than $2M per dose. Jean-Pierre
- Two4 2y agoJean-Pierre, This is an internet forum. Structuring your replies like an email is entirely too formal and comes across as stilted. Please feel free to treat it like a text message thread. Two4
- JPLeRouzic 2y agoThanks Two4